Does anesthesia choice affect clotting in prostate surgery? a trial investigates
NCT ID NCT07734233
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial compares spinal anesthesia (using bupivacaine) with general anesthesia in men undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia. Researchers measure blood clotting and breakdown markers before surgery and at 1 and 24 hours after, to see if the type of anesthesia influences coagulation and fibrinolysis. The study also tracks blood pressure, heart rate, and complications during and after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Spinal anesthesia (bupivacaine) or general anesthesia (propofol, fentanyl, rocuronium, sevoflurane)
- What this could lead to
- If one anesthesia method proves safer for blood clotting, it could guide choices for prostate surgery patients.
- What could go wrong
- This is a small, early-stage study focused on lab tests, not clinical outcomes. Results may not change practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
78 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male patients * Age ≥18 years * Scheduled for elective bipolar transurethral resection of the prostate * ASA physical status I-II * Ability to provide written informed consent Exclusion Criteria: * History of deep vein thrombosis or pulmonary embolism * Known inherited or acquired coagulation disorder * Severe hepatic insufficiency * Severe renal insufficiency * Use of anticoagulants, antiplatelet drugs, or NSAIDs within 10 days before surgery * Platelet count \<100 × 10⁹/L * INR \>1.5 * aPTT \>47 seconds * Contraindications to spinal anesthesia * Prostate malignancy * ASA physical status III or higher * Refusal to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sultangazi Haseki Training and Research Hospital
Istanbul, Istanbul, 34265, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Laser prostate surgery that spares ejaculation put to a Five-Year test
- Virtual basket laser mode put to the test for faster prostate surgery
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Listening to patients: a new way to guide prostate treatment?
- A surgical twist that could save ejaculation during prostate surgery
- Water jet surgery: a new wave for prostate relief?